课题基金 / 基金详情

Understanding the Physical Basis of gene/drug delivery with ultrasound and microbubbles

Understanding the Physical Basis of gene/drug delivery with ultrasound and microbubbles
了解超声波和微泡基因/药物输送的物理基础
批准号:
EP/F066740/1
负责人:
Robert Eckersley
金额:
$49.37万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --

项目摘要

项目成果

Robert Eckersley的其他基金

相似基金

相关文献

中文摘要
翻译
该项目的目的是利用超声和微泡造影剂相结合的方法提高药物和基因传递的有效性。有广泛的疾病,包括癌症和心脏病,这将受益于以安全、有效和局部的方式提供治疗剂的能力。尤其是基因治疗作为一种治疗遗传性和获得性疾病的方法具有巨大的潜力。这种治疗面临的主要问题是将足够的药物输送到身体的正确位置。目前使用病毒作为递送剂已显示出良好的效果,但我们身体的免疫反应问题限制了它们在临床上的应用潜力。其他方法目前的效率要低得多,必须与额外的物理增强相结合才能达到临床相关的效率。我们和其他人最近的研究表明,使用超声波和微泡相结合,有可能成为一种安全和定点的基因和药物传递的物理增强剂。微泡本身已经被用于诊断超声成像,以提高图像质量,并帮助检测疾病。它们实际上是微小的气泡,典型的大小与我们血液中流动的红细胞大小相同。它们含有惰性气体,以免溶解太快,通常由一层与肥皂泡相似的薄层稳定。超声波设备能够检测到它们,因为它们反射的声音非常强烈。在这个项目中,我们将以一种略有不同的方式使用这些气泡,增加我们使用的超声波的幅度,我们可以迫使气泡更有力地振荡,并导致气泡附近的细胞膜和小血管变得暂时泄漏。这种泄漏允许上述治疗性基因或药物进入需要它们的细胞。世界各地的一些研究小组对这一过程感兴趣,关于这一主题的出版文献越来越多。然而,到目前为止,大多数研究只是为了证明这一方法的可行性,而且它们调查的参数往往非常有限。在这项研究中,我们开展了一系列实验来研究这种方法背后的机制,从声音与微泡的相互作用到气泡振动对细胞的影响,无论是在培养中还是在临床前应用中。此外,我们将研究不同的气泡类型(具有不同的外壳和其他化学成分),以找到适合这种药物和基因传递过程的最佳微气泡特性。我们的目标有两个:一)深入了解这一过程的机制;二)优化技术,以获得最有效的治疗效果。从长远来看,患有癌症、心脏病和肌肉营养不良等遗传病的患者有朝一日将从这项研究中受益。
英文摘要
The aim of this project is to improve the effectiveness of drug and gene delivery using ultrasound combined with microbubble contrast agents. There are a wide range of diseases, including cancers and heart disease, which would benefit from the ability to deliver therapeutic agents in a safe, efficient, and localized manner. Gene therapy in particular has great potential as a method of treatment for both genetic and acquired diseases. The main problem facing this treatment is getting enough of the medicine to the right place in the body. Currently the use of viruses as delivery agents has shown good efficiency, however problems with the immune response of our bodies is a limit to their potential in clinical use. Other approaches are currently much less efficient and must be combined with additional physical enhancement to work at clinically relevant efficiencies. Recent research by us and others has shown that using ultrasound combined with microbubbles has the potential to act as a safe and site-specific physical enhancer of gene and drug delivery. Microbubbles themselves are already used in diagnostic ultrasound imaging to improve the image quality and aid in the detection of diseases. They are literally tiny bubbles, typical the same size as the red blood cells that flow in our blood. They contain an inert gas so as not to dissolve too quickly, and are usually stabilized by a thin layer not dissimilar to a soap bubble. The ultrasound equipment is able to detect them because they reflect the sound very strongly. In this project we will use these bubbles in a slightly different way, buy increasing the amplitude of the ultrasound that we use we can force the bubbles to oscillate more vigorously and to cause the cell membranes and small vessels near the bubbles to become temporarily leaky. This leakiness allows the therapeutic genes or drugs mentioned above to enter the cells where they are needed. A number of research groups around the world are interested in this process and there is a growing body of published literature on the topic. However, the majority of the studies to date act only to demonstrate the feasibility of this approach and are often very limited in the parameters they investigate. In this research we set out a series of experiments to investigate the mechanisms behind this approach from the interaction of the sound with the microbubbles through to the effect of the bubble vibrations on cells both in cultures and in pre-clinical applications. Additionally we will study different bubble types (with different shells and other chemical compositions) to find the optimum microbubble properties for this drug and gene delivery process. Our aims are twofold: i) to provide insight into the mechanisms that make this process work and ii) to optimise the technique to get the most effective therapeutic effect.In the long term a patients with cancers, heart disease and genetic diseases like muscle dystrophy will one day benefit from this research.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ultrasmedbio.2012.01.012
发表时间: 2012-05
期刊: ULTRASOUND IN MEDICINE AND BIOLOGY
影响因子: 2.9
作者: [Sennoga, Charles A., Yeh, James S. M., Alter, Julia, Stride, Eleanor, Nihoyannopoulos, Petros, Seddon, John M., Haskard, Dorian O., Hajnal, Joseph V., Tang, Meng-Xing, Eckersley, Robert J.]
通讯作者: Eckersley, Robert J.
Prospects for enhancement of targeted radionuclide therapy of cancer using ultrasound.
使用超声增强癌症靶向放射性核素治疗的前景。
DOI: 10.1002/jlcr.3157
发表时间: 2014
期刊: Journal of labelled compounds & radiopharmaceuticals
影响因子: 1.8
作者: [Browning RJ]
通讯作者: Browning RJ
Albumin coated microbubble optimization: custom fabrication and comprehensive characterization.
白蛋白包被的微泡优化:定制制造和综合表征。
DOI: 10.1016/j.ultrasmedbio.2012.05.002
发表时间: 2012
期刊: Ultrasound in medicine & biology
影响因子: 2.9
作者: [Mulvana H]
通讯作者: Mulvana H
Super Resolution Ultrasound Imaging
  • 批准号:
    EP/N014855/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $46.15万
  • 财政年份:
    2016
  • 负责人:
    Robert Eckersley
  • 依托单位:
Ultrafast contrast enhanced ultrasound for imaging and quantifying flow and tissue perfusion
  • 批准号:
    EP/M010961/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $7.15万
  • 财政年份:
    2014
  • 负责人:
    Robert Eckersley
  • 依托单位:
国内基金
海外基金
面向智能电网基础设施Cyber-Physical安全的自治愈基础理论研究
  • 批准号:
    61300132
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    王竹晓
  • 依托单位: